Pembrolizumab-Induced Demyelinating Polyradiculoneuropathy

Marie-Florence de Maleissye,Guillaume Nicolas,P. Saiag

Pembrolizumab-Induced Demyelinating Polyradiculoneuropathy

2016

Marie-Florence de Maleissye
Guillaume Nicolas
P. Saiag

This letter reports two cases of severe demyelinating polyradiculoneuropathy after treatment with pembrolizumab, a humanized antibody against programmed cell death 1 receptor, for advanced melanoma.

Keywords:

Oncology
Melanoma
Diabetes mellitus
Surgery
Pembrolizumab
Polyradiculoneuropathy
Humanized antibody
Medicine
Programmed Cell Death 1 Receptor
Internal medicine
advanced melanoma
after treatment

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations